Dating and marriage money red flags you should not ignore
The financial warning signs that matter long before joint accounts, EMIs, and shared goals enter the picture
We don’t follow questionable methodologies used by some economies: CEA Nageswaran
Criticism of GDP methods surfaces only when growth surprises on the upside, says the chief economic adviser
Subdued prices to continue weighing on steel profits, recovery in FY26 remains muted
Indian ferrous players are likely to witness an EBITDA/tonne contraction to the tune of Rs 2,000/tonne in the third quarter, given lower realisations and higher coking coal costs, according to JM Financial.
'Bad deal': New Zealand Foreign Minister attacks India FTA, vows to vote it down
In a strongly worded statement, Peters said his party was ‘regrettably opposed’ to the agreement
Accumulate Aarti Industries; target of Rs 403: Prabhudas Lilladher
Prabhudas Lilladher recommended accumulate rating on Aarti Industries with a target price of Rs 403 in its research report dated December 23, 2025.
Pine Labs shares rise 2% after Morgan Stanley, Jefferies issue bullish calls: Check target prices
Pine Labs share price: The stock has so far gained nearly 8% from its IPO price, but is around 2% lower than its listing price.
Gujarat Kidney and Super Speciality IPO crosses 2x subscription on Day 2 so far; check latest GMP
Shares of the company are proposed to be listed on the BSE and NSE on December 30, while the allotment is expected by December 26.
Hold Kajaria Ceramics; target of Rs 1083: Prabhudas Lilladher
Prabhudas Lilladher recommended hold rating on Kajaria Ceramics with a target price of Rs 1083 in its research report dated December 22, 2025.
India’s AIF industry confronts its disclosure dilemma
Closed-door talks between IVCA, rating agencies and family offices expose growing friction over disclosures, benchmarking and investor expectations as private funds go mainstream.
Buy GE Vernova TD India; target of Rs 4005: Prabhudas Lilladher
Prabhudas Lilladher is bullish on GE Vernova TD India has recommended buy rating on the stock with a target price of Rs 4005 in its research report dated December 23, 2025.
OPINION | Reimagining wealth management, a digital-first future
India’s wealth management industry needs to adopt fee-based advisory, digital tools, and hybrid models to serve a wider range of customers
GDP numbers unlikely to change with new series: MoSPI secretary Saurabh Garg
MoSPI to use GSTN and other digital datasets for better GSDP estimation; new GDP series is due February
Metal stocks rise for 5th day; NMDC, Hind Copper, SAIL, others gain up to 4%: What lies ahead?
Metal stocks: The Nifty Metal index has now recorded gains in 9 out of 10 straight sessions.
Anicut Capital closes Rs 1,275-crore private credit fund, to back consumer, engineering and SaaS players
The private credit fund will deploy capital across consumer, SaaS, manufacturing and engineering services companies, as mature businesses increasingly turn to non-dilutive financing
Neutral FSN E-Commerce Ventures; target of Rs 280: Motilal Oswal
Motilal Oswal recommended Neutral rating on FSN E-Commerce Ventures with a target price of Rs 280 in its research report dated December 23, 2025.
No case for passive investing in India for next decade as alpha lies outside indices: Vikas Khemani
Index investing in India is effectively a momentum strategy that captures stocks only after their strongest growth phase has passed; whereas, India’s economic transformation is throwing up outsized alpha and wealth-creation opportunities outside benchmark indices, said Vikas Khemani.
Buy Kajaria Ceramics; target of Rs 1252: Motilal Oswal
Motilal Oswal is bullish on Kajaria Ceramics recommended buy rating on the stock with a target price of Rs 1252 in its research report dated December 22, 2025.
Four reasons why Ranveer Singh's Hamza in 'Dhurandhar' has all the qualities of an ideal long-term investor
Hamza's quality of being patient to achieve his target in the spy drama is something long-term investors could imbibe to achieve excellent returns
'The pill is here': Novo Nordisk get USFDA nod for oral weight-loss therapy
The once-daily tablet of Wegovy is as effective as its blockbuster injectable version, the Danish drug maker said. It plans to launch the pill in the US early January
Buy Ambuja Cements; target of Rs 750: Motilal Oswal
Motilal Oswal is bullish on Ambuja Cements recommended buy rating on the stock with a target price of Rs 750 in its research report dated December 23, 2025.
Delayed US data expected to show solid growth in 3rd quarter
Forecasters expect Tuesday's third-quarter gross domestic product (GDP) report to show 3.2 percent growth, according to consensus estimates from MarketWatch and Trading Economics.
From stabilisation to growth: India's 2026 equity market outlook
Domestic investors are becoming disciplined and long-term. All we need is discipline in valuations in some pockets
Buy Akums Drugs and Pharmaceuticals; target of Rs 600: ICICI Direct
ICICI Direct is bullish on Akums Drugs and Pharmaceuticals recommended buy rating on the stock with a target price of Rs 600 in its research report dated December 22, 2025.
Sensex falls nearly 200 pts from day's high, Nifty below 26,200: 5 key reasons behind market decline
Sensex, Nifty declined as traders remained cautious amid expectations of subdued trading volumes during the holiday-shortened Christmas week.
